Author(s) : Tetsuya KOGA, Hong DUAN, Kazunori URABE, Masutaka FURUE, Department of Dermatology Graduate School of Medical Sciences Kyushu University 3-1-1, Maidashi, Higashi-ku J-812-858 Fukuoka Japan. |
ARTICLE
We appreciate the comments of McKenzie et al. on our recent paper
on immunohistochemical identification of IFN-gamma -positive cells in
psoriatic epidermis. By using our immunohistochemical technique in formalin-fixed,
paraffin-embedded sections, we have analyzed IFN-gamma expression in
situ in the keratinocytes of various types of skin inflammatory diseases.
Four of 6 patients with pustular psoriasis showed positive IFN-gamma
staining in keratinocytes. However, IFN-gamma -positive keratinocytes
were present in one of 5 in psoriasis vulgaris, one of 4 in
acute inflammatory tinea, one of 5 in spongiotic eczematous dermatitis,
and one of 6 in lichen planus. There are several possibilities for
IFN-gamma immunoreactivity in keratinocytes observed in our study. Keratinocytes
could pick up IFN-gamma from the circulation or neighbouring T cells on
their surface by binding IFN-gamma to its receptor. The intense staining
of IFN-gamma receptor was reported on keratinocytes in psoriasis [1].
Another possible explanation is the production and release of IFN-gamma
by keratinocytes. It is not clear why we could detect IFN-gamma expression
on keratinocytes in pustular psoriasis more frequently than in other types
of skin inflammatory diseases. The IFN-gamma -positive mononuclear lymphoid
cells in the epidermis were also obvious in the lesions of pustular psoriasis
[2]. IFN-gamma is believed to be an important mediator in psoriasis [3].
The local IFN-gamma expression in epidermis may contribute to the pathogenesis
in pustular psoriasis.
References
1. Ackermann L, Harvina IT, Pelkonen J, Ritamaki-Salo V, Naukkarinen
A, Harvina RJ, Horsmanheimo M. Mast cell in psoriatic skin are strongly
positive for interferon-gamma. Br J Dermatol 1999; 140: 624-33.
2. Koga T, Duan H, Urabe K, Furue M. In situ localization of IFN-gamma
positive cells in psoriatic lesional epidermis. Eur J Dermatol
2002; 12: 20-3.
3. Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts
and speculations. Immunol Today 1999; 20: 40-6.
|